QA: Edgewise Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001710072_2023_Edgewise_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001710072, Edgewise Therapeutics Inc.

  xvar xval
0 AssetsCurrent 356,999,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,533,000
3 remainder_Assets 1,569,000
4 LiabilitiesCurrent 16,585,000
5 LiabilitiesNoncurrent 3,800,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,626,000
9 ResearchAndDevelopmentExpense 54,032,000
10 remainder_Expenses 0
11 remainder_Revenues 4,018,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -841,000
  yvar yval
0 Assets 367,101,000
1 Liabilities 20,385,000
2 Expenses 71,658,000
3 Revenues 4,018,000
4 StockholdersEquity 346,716,000
5 NetIncome -67,640,000
6 ComprehensiveNetIncome -68,060,500
7 BaseVar 232,001,500
8 EconomicCapitalRatio 2.73

Edgar->Model Mapping

Feature Distribution

Change over Time